Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist PegvisomantPeter Trainer, John A. Scarlett, William M Drake et al.|New England Journal of Medicine|2000Cited by 874
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistAart Jan van der Lely, Michael O. Thorner, R. Kent Hutson et al.|The Lancet|2001Cited by 643
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority StudyAnnamaria Colao, Mônica R. Gadelha, Maria Fleseriu et al.|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 394